Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.
Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 16, 2022
Alchemab Therapeutics
|
Grant | £1.70M | Biotechnology | Yes |
Nov 5, 2012
Immunocore
|
Grant | £2.40M | Biotechnology | Yes |